INFLUENCE OF ADMINISTRATION OF ANTITHROMBIN CONCENTRATE IN CHILDREN ON HEPARIN INFUSION RATE DURING EXTRACORPOREAL MEMBRANE OXYGENATION
CP-174
SUCCESSFUL DESENSITISATION IN A PATIENT WITH LENALIDOMIDE HYPERSENSITIVITY
CP-111
ASSOCIATION BETWEEN POTASSIUM CHLORIDE INTRAVENOUS CONCENTRATION AND SEVERITY OF THE PAIN
CP-108
ADHERENCE TO PARENTERAL FIRST-LINE DISEASE-MODIFYING THERAPY FOR MULTIPLE SCLEROSIS
CP-087
PERSISTENCE OF INTRAMUSCULAR VERSUS SUBCUTANEOUS FIRST-LINE THERAPIES IN MULTIPLE SCLEROSIS PATIENTS
CP-056
PATIENT TREATMENT SATISFACTION AFTER SWITCHING TO BIWEEKLY SUBCUTANEOUS PEGINTERFERON BETA 1A FROM INTRAMUSCULAR INTERFERON BETA 1A
CP-237
ANALYSIS OF SURVIVAL IN PATIENTS DIAGNOSED WITH METASTATIC
CP-231
IMPLEMENTATION OF MEDICATION RECONCILIATION ON ADMISSION IN A PSYCHIATRIC HOSPITAL: WHO COMES FIRST?
CP-229
ANTIVITAMIN K OVERDOSE: HOW TO USE VITAMIN K1?
CP-225
UGT1A1*28 POLYMORPHISM AND IRINOTECAN EFFECTIVENESS
CP-218
MEDICATION DISCREPANCIES AND THEIR CLINICAL IMPACT: A STUDY AT THE EMERGENCY DEPARTMENT
CP-216
USING RITUXIMAB FOR OFF-LABEL INDICATIONS
CP-204
OBSERVATIONAL STUDY ON THE USE OF THE DIFFERENT THERAPEUTIC ALTERNATIVES FOR MULTIPLE SCLEROSIS TREATMENT
CP-199
PRESCRIPTION OF QUINOLONES, CARBAPENEMS AND ANTI-MRSA AGENTS IN THE EMERGENCY DEPARTMENT OF A DISTRICT HOSPITAL: INTERVENTIONS AND DEVELOPMENT OVER 3 YEARS
CP-198
REVIEW OF INTRAVENOUS IRON PRESCRIPTIONS: FOCUS ON DOSING
